The expression levels of CD73 and CD39 were further increased upon disease progression on nB cells and T cells (Figure 1B,C), while leukemic CLL cells maintained high levels of both ectonucletotidases (Figure 1D). This evidence concerns the gene ENTPD1 and B-cell chronic lymphocytic leukemia.